CNS Pharmaceuticals News

CNS Pharmaceuticals | 8-K: Current report

Dec 11 12:30 ET

CNS Pharmaceuticals | 8-K: Current report

Dec 3 11:35 ET

CNS Pharmaceuticals | DEFR14A: Definitive proxy statement in connection with contested solicitations

Nov 15 16:23 ET

CNS Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 14 17:07 ET

CNS Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(3.20%),Steven Boyd(3.20%)

Nov 14 16:03 ET

CNS Pharmaceuticals | 8-K: Current report

Nov 1 09:02 ET

CNS Pharmaceuticals | DEF 14A: Definitive information statements

Oct 28 16:20 ET

CNS Pharmaceuticals | 8-K: Current report

Oct 24 17:29 ET

CNS Pharmaceuticals | 424B5: Prospectus

Oct 24 11:28 ET

CNS Pharmaceuticals | 8-K: Current report

Oct 23 08:05 ET

CNS Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Oct 15 17:25 ET

CNS Pharmaceuticals | 8-K: Current report

Sep 18 16:33 ET

CNS Pharmaceuticals | 8-K: Current report

Sep 12 09:03 ET

CNS Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 14 17:26 ET

CNS Pharmaceuticals | 8-K: Current report

Aug 7 07:31 ET

CNS Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Cortice Biosciences, Inc.

Aug 6 17:14 ET

CNS Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Cortice Biosciences, Inc.

Aug 6 16:58 ET

CNS Pharmaceuticals | EFFECT: Others

Aug 5 06:07 ET

CNS Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Cortice Biosciences, Inc.(5.7%)

Aug 2 16:16 ET

CNS Pharmaceuticals | RW: Registration Withdrawal Request

Jul 31 12:36 ET